Coverart for item
The Resource Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy

Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy

Label
Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy
Title
Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy
Creator
Contributor
Subject
Language
eng
Member of
Cataloging source
MiAaPQ
Literary form
non fiction
Nature of contents
dictionaries
Series statement
SpringerBriefs in Applied Sciences and Technology Ser
Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy
Label
Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy
Link
http://libproxy.rpi.edu/login?url=https://ebookcentral.proquest.com/lib/rpi/detail.action?docID=4767563
Publication
Copyright
Related Contributor
Related Location
Related Agents
Related Authorities
Related Subjects
Related Items
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
Acknowledgements -- Contents -- About the Authors -- 1 Current Status and Characteristics of Cancer -- 1.1 Abnormal Metabolism -- 1.2 Abnormal Vasculature -- 1.3 Resistance to Anti-proliferative Growth Factors (GFs) -- 1.4 Unlimited Replicative Potential -- 1.5 Immune System Activation and Inflammation -- 1.6 Interstitial Pressure -- References -- 2 Clinical Anticancer Drugs for Cancer Treatment -- 2.1 Antimetabolites -- 2.2 Antimitotic Agents -- 2.3 Alkylating Agents -- 2.4 Antitumor Antibiotics -- 2.5 Tyrosine Kinase Inhibitors (TKI) -- 2.6 Cyclin Dependent Kinase (CDK) Inhibitors -- 2.7 Poly(ADP-Ribose) Polymerase (PARP) Inhibitors -- 2.8 Histone Deacetyltransferase Inhibitors (HDACi) -- 2.9 Mitogen-Activated Protein Kinase (MAPK) Kinase (MEK) Inhibitors -- 2.10 Serine/Threonine-Protein Kinase B-Raf Inhibitors -- 2.11 Mammalian Target of Rapamycin (MTOR) Inhibitors -- 2.12 Phosphoinositide 3-Kinase (PI3K) Inhibitors -- 2.13 Ribonucleotide Reductase (RNR) Inhibitors -- 2.14 DNA Methyltransferase Inhibitors -- 2.15 Retinoids -- 2.16 Monoclonal Antibodies (MAbs) -- 2.17 Combination Therapy -- References -- 3 Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy -- 3.1 Introduction -- 3.2 Organic Nanomaterials -- 3.2.1 FDA-Approved Liposomes -- 3.2.2 Polymer-Based Nanoparticles -- 3.2.3 Supramolecular Nanosystems -- 3.2.4 Others -- 3.3 Inorganic Nanomaterials -- 3.3.1 Quantum Dots -- 3.3.2 Gold Nanomaterials -- 3.3.2.1 Gold Nanoparticles -- 3.3.2.2 Gold Nanorods -- 3.3.3 Mesoporous Silica Nanoparticles -- 3.3.4 Carbon Nanomaterials -- 3.3.4.1 Carbon Nanotubes -- 3.3.4.2 Graphene -- 3.3.4.3 Carbon Dots -- 3.3.5 Upconversion Nanoparticles -- 3.3.6 Two-Dimensional Nanomaterials -- 3.3.7 Others -- 3.4 Organic-Inorganic Hybrid Nanomaterials -- References -- Conclusions
http://library.link/vocab/cover_art
https://contentcafe2.btol.com/ContentCafe/Jacket.aspx?Return=1&Type=S&Value=9789811032998&userID=ebsco-test&password=ebsco-test
Dimensions
unknown
http://library.link/vocab/discovery_link
{'f': 'http://opac.lib.rpi.edu/record=b4387041'}
Extent
1 online resource (62 pages)
Form of item
online
Isbn
9789811032998
Media category
computer
Media MARC source
rdamedia
Media type code
c
Sound
unknown sound
Specific material designation
remote

Library Locations

    • Folsom LibraryBorrow it
      110 8th St, Troy, NY, 12180, US
      42.729766 -73.682577
Processing Feedback ...